Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? Yes
Write-up: Dyspnoea; Vigilance decreased; Pneumonia bacterial; Exsiccosis; This is a spontaneous report from a non-contactable physician received from regulatory authority, downloaded from the Agency, DE-PEI-PEI2021003160. A 98-year-old female patient received BNT162B2 (COMIRNATY, batch/lot number: EM0477) via an unspecified route of administration on an unspecified date (unknown age at vaccination) at single dose for COVID-19 immunization. The patient''s medical history included dementia and unknown if ongoing. Before vaccination there are no typical symptoms of infections; the patient was stable. Concomitant medications were not reported. After vaccination, on 01Feb2021 the patient developed dyspnea, vigilance decreased, exsiccosis, and pneumonia bacterial, lasting for unknown. The condition was life threatening. The patient died on 05Feb2021. It was not reported if an autopsy was performed. The outcome of the events was fatal. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death:
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166